Evidence map›Paper›PMID 28777381›Full record

ArticleThe ISME journal2017

Mixotrophy drives niche expansion of verrucomicrobial methanotrophs.

Carlo R Carere, Kiel Hards, Karen M Houghton, Jean F Power, Ben McDonald, Christophe Collet, Daniel J Gapes, Richard Sparling, Eric S Boyd, Gregory M Cook and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The ISME journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Microbial oxidation of atmospheric trace gases.Nature reviews. Microbiology · 2022
    Review
  19. Article
  20. Sulfur and methane oxidation by a single microorganism.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Carlo R CarereExtremophile Research Group, GNS Science, Taupō, New Zealand.
Kiel HardsDepartment of Microbiology and Immunology, University of Otago, New Zealand.
Karen M HoughtonExtremophile Research Group, GNS Science, Taupō, New Zealand.
Jean F PowerExtremophile Research Group, GNS Science, Taupō, New Zealand.
Ben McDonaldScion, Te Papa Tipu Innovation Park, Rotorua, New Zealand.
Christophe ColletScion, Te Papa Tipu Innovation Park, Rotorua, New Zealand.
Daniel J GapesScion, Te Papa Tipu Innovation Park, Rotorua, New Zealand.
Richard SparlingDepartment of Microbiology, University of Manitoba, MB, Canada.
Eric S BoydDepartment of Microbiology and Immunology, Montana State University, MT, USA.
Gregory M CookDepartment of Microbiology and Immunology, University of Otago, New Zealand.
Chris GreeningDepartment of Microbiology and Immunology, University of Otago, New Zealand.
Matthew B StottExtremophile Research Group, GNS Science, Taupō, New Zealand.
GNS Science · NZMuseum of New Zealand Te Papa Tongarewa · NZUniversity of Otago · NZMontana State University · USScion · NZUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aerobic methanotrophic bacteria have evolved a specialist lifestyle dependent on consumption of methane and other short-chain carbon compounds. However, their apparent substrate specialism runs contrary to the high relative abundance of these microorganisms in dynamic environments, where the availability of methane and oxygen fluctuates. In this work, we provide in situ and ex situ evidence that verrucomicrobial methanotrophs are mixotrophs. Verrucomicrobia-dominated soil communities from an acidic geothermal field in Rotokawa, New Zealand rapidly oxidised methane and hydrogen simultaneously. We isolated and characterised a verrucomicrobial strain from these soils, Methylacidiphilum sp. RTK17.1, and showed that it constitutively oxidises molecular hydrogen. Genomic analysis confirmed that this strain encoded two [NiFe]-hydrogenases (group 1d and 3b), and biochemical assays revealed that it used hydrogen as an electron donor for aerobic respiration and carbon fixation. While the strain could grow heterotrophically on methane or autotrophically on hydrogen, it grew optimally by combining these metabolic strategies. Hydrogen oxidation was particularly important for adaptation to methane and oxygen limitation. Complementary to recent findings of hydrogenotrophic growth by Methylacidiphilum fumariolicum SolV, our findings illustrate that verrucomicrobial methanotrophs have evolved to simultaneously utilise hydrogen and methane from geothermal sources to meet energy and carbon demands where nutrient flux is dynamic. This mixotrophic lifestyle is likely to have facilitated expansion of the niche space occupied by these microorganisms, allowing them to become dominant in geothermally influenced surface soils. Genes encoding putative oxygen-tolerant uptake [NiFe]-hydrogenases were identified in all publicly available methanotroph genomes, suggesting hydrogen oxidation is a general metabolic strategy in this guild.

Indexed as

Soil MicrobiologyAutotrophic ProcessesBacterial ProteinsGenomicsHydrogenaseMethaneNew ZealandOxidation-ReductionOxygenPhylogenySoilVerrucomicrobiaBacterial ProteinsHydrogenaseMethanenickel-iron hydrogenaseOxygenSoil

Identifiers

PMID28777381
PMCPMC5649168
OpenAlexW2742801096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.